AFP and neoplasm: Laboratory studies demonstrate that RECAF can be used alone as an aspecific tumor marker, because, unlike AFP, it is found on the cell membranes of most types of tumors with a low degree of differentiation (and therefore, it cannot be said to be a universal type of marker) [39,42].